Catalyst

Slingshot members are tracking this event:

Mast Therapeutics Announces Initiation Of Phase 2 Study Of AIR001 Conducted By The Heart Failure Clinical Research Network

Source Link:
http://masttherapeutics.com/investors/news/?releaseid=2191341

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
MSTX
100%
SIGN ME UP
I want to vote! LOG ME IN
Now!

Additional Information

Additional Relevant Details  The 100-patient study, known as the Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF (INDIE-HFpEF) study, is sponsored by Duke Clinical Research Institute (DCRI) as the Coordinating Center for the Heart Failure Clinical Research Network (HFN) and is being conducted at premier clinical centers that are part of the HFN.
http://masttherapeut...
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
Aug 01, 2016
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Heart Failure, Air001, Phase 2, Hfpef
About Us
Media Center
Connect with Us
© 2025 Slingshot Insights. All rights reserved.